Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company specializing in the development of RNA interference (RNAi) therapeutics for the treatment of cancer and other diseases. With a focus on overcoming limitations of existing RNAi technologies, Phio Pharma aims to deliver innovative solutions utilizing its proprietary self-delivering RNAi (sd-rxRNA) therapeutic platform. The company's sd-rxRNA molecules have the potential to selectively silence disease-causing genes, providing a targeted approach to therapeutic intervention. Phio Pharma is dedicated to improving patients' lives by advancing the field of RNAi therapeutics through rigorous research, development, and collaboration with industry partners.